Skip to content

Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease

Assessment of the Effect of Restriction on Alimentary AGE (Advanced Glycation Products) in Progression of Chronic Kidney Disease (CKD)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04827290
Acronym
CKD AGE
Enrollment
66
Registered
2021-04-01
Start date
2024-08-01
Completion date
2025-09-01
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease stage3, Chronic Kidney Disease Stage 3A (Disorder), Chronic Kidney Disease Stage 3B, Chronic Kidney Disease, Stage 3 (Moderate), Diet Habit, Kidney Failure, Chronic

Keywords

kidney failure, advanced glycation products, chronic kidney disease

Brief summary

Normal-protein and low-AGE through raw or rare proteins diet versus normal-protein and high-AGE diet in stage IIIa-b renal failure patients

Interventions

BEHAVIORALLow-AGE diet

Low-AGE diet during 24 months

BEHAVIORALHigh-AGE diet

High-AGE diet during 24 months

Sponsors

Centre Hospitalier Saint Joseph Saint Luc de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients with a grade IIIA-B CKD (GFR with CKD-EPI ≥ 30 mL/min and \< 60mL/min) * Informed consent signed * Aged 18 to 89 years

Exclusion criteria

* Protected adult * Acute renal failure * Patient already on a low-AGE diet (\< 1kU AGE/day) following a dietetic consultation * Current participation in another interventional research

Design outcomes

Primary

MeasureTime frameDescription
Glomerular Filtration RateAt 24 monthsGlomerular Filtration Rate estimated by the CKD-EPI formula with a blood sample

Secondary

MeasureTime frameDescription
ProteinuriaAt 24 monthsProteinuria (g/24h) found in the 24-hour urine

Countries

France

Contacts

Primary ContactFanny Doroszewski
fdoroszewski@chsjsl.fr0033478618398
Backup ContactGabrielle Normand, MD
lgnormand@chsjsl.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026